Lifevantage Corp: Form 10-K for the period ended Jun 30, 2021
Filed with the SEC on Aug 19, 2021 and accepted by EDGAR at Aug 19, 2021, 16:06 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2021-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2021-04-01 to 2021-06-30 | $54.8m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 12 months2020-07-01 to 2021-06-30 | $220.2m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months2020-07-01 to 2021-06-30 | $38.2m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2021-04-01 to 2021-06-30 | $45.0m | us-gaap:GrossProfit |
| Gross profit | 12 months2020-07-01 to 2021-06-30 | $182.0m | us-gaap:GrossProfit |
| Research and development | 12 months2020-07-01 to 2021-06-30 | $700.0k | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months2020-07-01 to 2021-06-30 | $60.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2020-07-01 to 2021-06-30 | $17.6m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2020-07-01 to 2021-06-30 | $17.0k | us-gaap:InterestExpense |
| Income tax | 12 months2020-07-01 to 2021-06-30 | $4.3m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2021-04-01 to 2021-06-30 | $4.9m | us-gaap:NetIncomeLoss |
| Net income | 12 months2020-07-01 to 2021-06-30 | $12.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2021-04-01 to 2021-06-30 | $0.35 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 12 months2020-07-01 to 2021-06-30 | $0.90 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2021-04-01 to 2021-06-30 | $0.36 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 12 months2020-07-01 to 2021-06-30 | $0.92 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2020-07-01 to 2021-06-30 | 14,268,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2020-07-01 to 2021-06-30 | $16.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2020-07-01 to 2021-06-30 | $3.7m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 12 months2020-07-01 to 2021-06-30 | $11.9m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2021-06-30 | $23.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2021-06-30 | $48.1m | us-gaap:AssetsCurrent |
| Total assets | At period end2021-06-30 | $78.7m | us-gaap:Assets |
| Current liabilities | At period end2021-06-30 | $25.2m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2021-06-30 | $41.9m | us-gaap:Liabilities |
| Shareholders' equity | At period end2021-06-30 | $36.8m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000849146-21-000078. Last ingested by Listed: Nov 13, 2026, 14:58 ET. Listed shows no prices and gives no investment advice.